Comparing the quality of antidepressant pharmacotherapy in the Department of Veterans Affairs and the Private Sector

Susan H. Busch, Douglas Leslie, Robert A. Rosenheck

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Objective: Comparing quality of care between large health care systems is important for health systems management. This study compared measures of the quality of phamacotherapy for patients with major depression across a sample of patients from the Department of Veterans Affairs (VA) and the private sector. Methods: In this observational study, all patients who were given a new prescription for an antidepressant and a diagnosis of major depression in the VA during fiscal year 2000 were identified by using administrative data (N=27,713). In the private sector, a similar sample of patients were identified by using Medstat's MarketScan database (N=4,852). For both groups, measures of the quality of antidepressant pharmacotherapy were constructed. These measures were compared across the two groups by using logistic regression models. Controls for age, gender, comorbid disorders, and initial anti-depressant drug prescribed were included in some models. Results: Although the populations had different demographic and clinical characteristics, differences in the quality measures between the two systems were few, with the VA slightly outperforming the private sector in the prescription of antidepressants during the acute phase of treatment, the first 84 days (84.7 compared with 81 percent) and during the maintenance phase of treatment, the first 181 days (53.9 compared with 50.9 percent). Patient characteristics that were associated with quality measures included being older, being female, and having a comorbid diagnosis of substance use disorder, bipolar disorder, or anxiety or adjustment disorder. Conclusions: Both systems had relatively high rates of adherence to pharmacotherapy guidelines. Even though the populations in the two systems were different, adjusting the analyses for clinical characteristics did little to change the measured differences between the two systems.

Original languageEnglish (US)
Pages (from-to)1386-1391
Number of pages6
JournalPsychiatric Services
Volume55
Issue number12
DOIs
StatePublished - Dec 1 2004

Fingerprint

Private Sector
Veterans
Antidepressive Agents
Drug Therapy
Prescriptions
Logistic Models
Depression
Adjustment Disorders
Quality of Health Care
Anxiety Disorders
Bipolar Disorder
Population
Substance-Related Disorders
Observational Studies
Maintenance
Demography
Databases
Guidelines
Delivery of Health Care
Health

All Science Journal Classification (ASJC) codes

  • Psychiatry and Mental health

Cite this

@article{495870434234452789e0f889f94a333b,
title = "Comparing the quality of antidepressant pharmacotherapy in the Department of Veterans Affairs and the Private Sector",
abstract = "Objective: Comparing quality of care between large health care systems is important for health systems management. This study compared measures of the quality of phamacotherapy for patients with major depression across a sample of patients from the Department of Veterans Affairs (VA) and the private sector. Methods: In this observational study, all patients who were given a new prescription for an antidepressant and a diagnosis of major depression in the VA during fiscal year 2000 were identified by using administrative data (N=27,713). In the private sector, a similar sample of patients were identified by using Medstat's MarketScan database (N=4,852). For both groups, measures of the quality of antidepressant pharmacotherapy were constructed. These measures were compared across the two groups by using logistic regression models. Controls for age, gender, comorbid disorders, and initial anti-depressant drug prescribed were included in some models. Results: Although the populations had different demographic and clinical characteristics, differences in the quality measures between the two systems were few, with the VA slightly outperforming the private sector in the prescription of antidepressants during the acute phase of treatment, the first 84 days (84.7 compared with 81 percent) and during the maintenance phase of treatment, the first 181 days (53.9 compared with 50.9 percent). Patient characteristics that were associated with quality measures included being older, being female, and having a comorbid diagnosis of substance use disorder, bipolar disorder, or anxiety or adjustment disorder. Conclusions: Both systems had relatively high rates of adherence to pharmacotherapy guidelines. Even though the populations in the two systems were different, adjusting the analyses for clinical characteristics did little to change the measured differences between the two systems.",
author = "Busch, {Susan H.} and Douglas Leslie and Rosenheck, {Robert A.}",
year = "2004",
month = "12",
day = "1",
doi = "10.1176/appi.ps.55.12.1386",
language = "English (US)",
volume = "55",
pages = "1386--1391",
journal = "Psychiatric Services",
issn = "1075-2730",
publisher = "American Psychiatric Association",
number = "12",

}

Comparing the quality of antidepressant pharmacotherapy in the Department of Veterans Affairs and the Private Sector. / Busch, Susan H.; Leslie, Douglas; Rosenheck, Robert A.

In: Psychiatric Services, Vol. 55, No. 12, 01.12.2004, p. 1386-1391.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Comparing the quality of antidepressant pharmacotherapy in the Department of Veterans Affairs and the Private Sector

AU - Busch, Susan H.

AU - Leslie, Douglas

AU - Rosenheck, Robert A.

PY - 2004/12/1

Y1 - 2004/12/1

N2 - Objective: Comparing quality of care between large health care systems is important for health systems management. This study compared measures of the quality of phamacotherapy for patients with major depression across a sample of patients from the Department of Veterans Affairs (VA) and the private sector. Methods: In this observational study, all patients who were given a new prescription for an antidepressant and a diagnosis of major depression in the VA during fiscal year 2000 were identified by using administrative data (N=27,713). In the private sector, a similar sample of patients were identified by using Medstat's MarketScan database (N=4,852). For both groups, measures of the quality of antidepressant pharmacotherapy were constructed. These measures were compared across the two groups by using logistic regression models. Controls for age, gender, comorbid disorders, and initial anti-depressant drug prescribed were included in some models. Results: Although the populations had different demographic and clinical characteristics, differences in the quality measures between the two systems were few, with the VA slightly outperforming the private sector in the prescription of antidepressants during the acute phase of treatment, the first 84 days (84.7 compared with 81 percent) and during the maintenance phase of treatment, the first 181 days (53.9 compared with 50.9 percent). Patient characteristics that were associated with quality measures included being older, being female, and having a comorbid diagnosis of substance use disorder, bipolar disorder, or anxiety or adjustment disorder. Conclusions: Both systems had relatively high rates of adherence to pharmacotherapy guidelines. Even though the populations in the two systems were different, adjusting the analyses for clinical characteristics did little to change the measured differences between the two systems.

AB - Objective: Comparing quality of care between large health care systems is important for health systems management. This study compared measures of the quality of phamacotherapy for patients with major depression across a sample of patients from the Department of Veterans Affairs (VA) and the private sector. Methods: In this observational study, all patients who were given a new prescription for an antidepressant and a diagnosis of major depression in the VA during fiscal year 2000 were identified by using administrative data (N=27,713). In the private sector, a similar sample of patients were identified by using Medstat's MarketScan database (N=4,852). For both groups, measures of the quality of antidepressant pharmacotherapy were constructed. These measures were compared across the two groups by using logistic regression models. Controls for age, gender, comorbid disorders, and initial anti-depressant drug prescribed were included in some models. Results: Although the populations had different demographic and clinical characteristics, differences in the quality measures between the two systems were few, with the VA slightly outperforming the private sector in the prescription of antidepressants during the acute phase of treatment, the first 84 days (84.7 compared with 81 percent) and during the maintenance phase of treatment, the first 181 days (53.9 compared with 50.9 percent). Patient characteristics that were associated with quality measures included being older, being female, and having a comorbid diagnosis of substance use disorder, bipolar disorder, or anxiety or adjustment disorder. Conclusions: Both systems had relatively high rates of adherence to pharmacotherapy guidelines. Even though the populations in the two systems were different, adjusting the analyses for clinical characteristics did little to change the measured differences between the two systems.

UR - http://www.scopus.com/inward/record.url?scp=9644289365&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9644289365&partnerID=8YFLogxK

U2 - 10.1176/appi.ps.55.12.1386

DO - 10.1176/appi.ps.55.12.1386

M3 - Article

C2 - 15572566

AN - SCOPUS:9644289365

VL - 55

SP - 1386

EP - 1391

JO - Psychiatric Services

JF - Psychiatric Services

SN - 1075-2730

IS - 12

ER -